Immix Biopharma
IMMX
IMMX
12 hedge funds and large institutions have $406K invested in Immix Biopharma in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 0 closing their positions.
Holders
12
Holders Change
+5
Holders Change %
+71.43%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $143K | 105,125 | +54,220 | +107% |
|
2
Geode Capital Management
Boston,
Massachusetts
| $104K | 76,769 | +3,436 | +5% |
|
3
State Street
Boston,
Massachusetts
| $58K | 42,960 | +4,400 | +11% |
|
4
Renaissance Technologies
New York
| $37K | 27,050 | +27,050 | New |
|
5
Northern Trust
Chicago,
Illinois
| $26K | 19,151 | +19,151 | New |
|
|
ICG
6
InterOcean Capital Group
Nashville,
Tennessee
| $22K | 15,900 | – | – |
|
7
UBS Group
Zurich,
Switzerland
| $16K | 12,004 | +7,667 | +177% |
|
8
Wells Fargo
San Francisco,
California
| $0 | 36 | -34 | -49% |
|
|
CFGS
9
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
10
Osaic Holdings
Scottsdale,
Arizona
| $0 | 350 | – | – |
|
11
Morgan Stanley
New York
| $0 | 3 | +3 | New |
|
12
Fidelity Investments
Boston,
Massachusetts
| $0 | 9 | +9 | New |
|
|
TRCT
13
Tower Research Capital (TRC)
New York
| $0 | 250 | +250 | New |
|